Cancer Drugs
Trodelvy
Also known as: Sacituzumab govitecan, Anti-Trop-2 ADC
Definition
Sacituzumab govitecan, an antibody-drug conjugate targeting Trop-2, used in metastatic triple-negative and HR+/HER2- breast cancer.
Detailed Explanation
Trodelvy links an anti–Trop-2 antibody with a SN-38 payload, delivering chemotherapy directly to cancer cells. It is used after prior lines of therapy.